Exhaled particles as markers of small airway inflammation in subjects with asthma

Clinical Physiology and Functional Imaging

Volumn 37, Issue 5, 2017, Pages 489-497

  Larsson, Per ^a   Lärstad, Mona ^a   Bake, Björn ^a   Hammar, Oscar ^a   Bredberg, Anna ^a   Almstrand, Ann Charlotte ^a   Mirgorodskaya, Ekaterina ^a   Olin, Anna Carin ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

aerosol; airway opening; albumin; asthma; birch pollen; exhaled breath condensate; exhaled particles; inflammation; surfactant protein A

Indexed keywords

ALBUMIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GLUCOCORTICOID; SURFACTANT PROTEIN A; ALB PROTEIN, HUMAN; BIOLOGICAL MARKER; HUMAN SERUM ALBUMIN; NITRIC OXIDE;

ADULT; AEROSOL; ARTICLE; BIRCH; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL LINING FLUID; EXHALATION; FEMALE; HUMAN; INHALATION; LUNG FUNCTION TEST; MALE; MILD INTERMITTENT ASTHMA; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; RESPIRATORY TRACT INFLAMMATION; SMALL AIRWAY DISEASE; SPIROMETRY; ASTHMA; IMMUNOLOGY; LUNG; METABOLISM; MIDDLE AGED; PARTICLE SIZE; PATHOPHYSIOLOGY; PNEUMONIA; POLLEN; PREDICTIVE VALUE; YOUNG ADULT;

ADULT; AEROSOLS; ASTHMA; BETULA; BIOMARKERS; BREATH TESTS; EXHALATION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; PARTICLE SIZE; PNEUMONIA; POLLEN; PREDICTIVE VALUE OF TESTS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; RHINITIS, ALLERGIC, SEASONAL; SERUM ALBUMIN, HUMAN; SPIROMETRY; YOUNG ADULT;

EID: 84949818311     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/cpf.12323     Document Type: Article

References (37)

1. Almstrand AC, Ljungstrom E, Lausmaa J, et al. Airway monitoring by collection and mass spectrometric analysis of exhaled particles. Anal Chem (2009); 81: 662–668.
2. Almstrand AC, Bake B, Ljungstrom E, et al. Effect of airway opening on production of exhaled particles. J Appl Physiol (1985) (2010); 108: 584–588.
3. Bake B, Viklund E, Olin AC. Effects of pollen season on central and peripheral nitric oxide production in subjects with pollen asthma. Respir Med (2014); 108: 1277–1283.
4. Bernhard W, Haagsman HP, Tschernig T, et al. Conductive airway surfactant: surface-tension function, biochemical composition, and possible alveolar origin. Am J Respir Cell Mol Biol (1997); 17: 41–50.
5. Braunstahl GJ. The unified immune system: respiratory tract-nasobronchial interaction mechanisms in allergic airway disease. J Allergy Clin Immunol (2005); 115: 142–148.
6. Bredberg A, Gobom J, Almstrand AC, et al. Exhaled endogenous particles contain lung proteins. Clin Chem (2012); 58: 431–440.
7. Cheng G, Ueda T, Numao T, et al. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J (2000); 16: 831–835.
8. D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy (2007); 62: 976–990.
9. DellaValle CT, Triche EW, Leaderer BP, et al. Effects of ambient pollen concentrations on frequency and severity of asthma symptoms among asthmatic children. Epidemiology (2012); 23: 55–63.
10. Erpenbeck VJ, Schmidt R, Gunther A, et al. Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma. Allergy (2006); 61: 598–604.
11. Haslbeck K, Schwarz K, Hohlfeld JM, et al. Submicron droplet formation in the human lung. J Aerosol Sci (2010); 41: 429–438.
12. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med (1999); 159: 646–678.
13. Hohlfeld JM, Erpenbeck VJ, Krug N. Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma. Pathobiology (2002); 70: 287–292.
14. Holmgren H, Ljungstrom E. Influence of film dimensions on film droplet formation. J Aerosol Med Pulm Drug Deliv (2012); 25: 47–53.
15. Holmgren H, Ljungstrom E, Almstrand AC, et al. Size distribution of exhaled particles in the range from 0.01 to 2.0 mu m. J Aerosol Sci (2010); 41: 439–446.
16. Jantunen J, Saarinen K, Rantio-Lehtimaki A. Allergy symptoms in relation to alder and birch pollen concentrations in Finland. Aerobiologia (2012); 28: 169–176.
17. Jarjour NN, Enhorning G. Antigen-induced airway inflammation in atopic subjects generates dysfunction of pulmonary surfactant. Am J Respir Crit Care Med (1999); 160: 336–341.
18. Johnson GR, Morawska L. The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug Deliv (2009); 22: 229–237.
19. Kampe M, Janson C, Stalenheim G, et al. Experimental and seasonal exposure to birch pollen in allergic rhinitis and allergic asthma with regard to the inflammatory response. Clin Respir J (2010); 4: 37–44.
20. Khor YH, Teoh AKY, Lam SM, et al. Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. Clin Exp Allergy (2009); 39: 1659–1667.
21. Kishore U, Bernal AL, Kamran MF, et al. Surfactant proteins SP-A and SP-D in human health and disease. Archivum immunologiae et therapiae experimentalis (2005); 53: 399–417.
22. Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol (2006); 43: 1293–1315.
23. Knowles MR, Robinson JM, Wood RE, et al. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects. J Clin Investig (1997); 100: 2588–2595.
24. Koopmans JG, van der Zee JS, Krop EJ, et al. Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy (2004); 34: 1827–1833.
25. Larsson P, Mirgorodskaya E, Samuelsson L, et al. Surfactant protein A and albumin in particles in exhaled air. Respir Med (2012); 106: 197–204.
26. McEntee WR, Mysels KJ. Bursting of soap films. I. An experimental study. J Phys Chem (1969); 73: 3018–3028.
27. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J (2005); 26: 319–338.
28. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth (2000); 85: 599–610.
29. Perez-Gil J. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta (2008); 1778: 1676–1695.
30. Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993); 16: 5–40.
31. Schurch S, Lee M, Gehr P. Pulmonary surfactant – surface-properties and function of alveolar and airway surfactant. Pure Appl Chem (1992); 64: 1745–1750.
32. Schwarz K, Biller H, Windt H, et al. Characterization of exhaled particles from the healthy human lung–a systematic analysis in relation to pulmonary function variables. J Aerosol Med Pulm Drug Deliv (2010); 23: 371–379.
33. Schwarz K, Biller H, Windt H, et al. Characterization of exhaled particles from the human lungs in airway obstruction. J Aerosol Med Pulm Drug Deliv (2015); 28: 52–58.
34. Taylor PE, Jacobson KW, House JM, et al. Links between pollen, atopy and the asthma epidemic. Int Arch Allergy Immunol (2007); 144: 162–170.
35. Tilles SA, Bardana EJ Jr. Seasonal variation in bronchial hyperreactivity (BHR) in allergic patients. Clin Rev Allergy Immunol (1997); 15: 169–185.
36. Widdicombe JH. Regulation of the depth and composition of airway surface liquid. J Anat (2002); 201: 313–318.
37. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol (2005); 5: 58–68.